Increased plasma amyloid β protein 1-42 levels in Down syndrome

Neuroscience Letters

Volumn 241, Issue 1, 1998, Pages 13-16

  Mehta, Pankaj D ^a   Dalton, Arthur J ^a   Mehta, Sangita P ^a   Kim, Kwang Soo ^a   Sersen, Eugene A ^a   Wisniewski, Henryk M ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Amyloid protein 1 40; Amyloid protein 1 42; Down syndrome; Enzyme linked immunosorbent assay; Mentally retarded; Normal controls; Plasma

Indexed keywords

AMYLOID BETA PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; AMYLOID BETA-PROTEIN; DOWN SYNDROME; FEMALE; GENE DOSAGE; HUMANS; MALE; MENTAL RETARDATION; MIDDLE AGED; PEPTIDE FRAGMENTS; TRISOMY;

EID: 0032559268     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00966-X     Document Type: Article

References (18)

1. Gravina S.A., Libin H., Eckman C.B., Long K.E., Otvos L. Jr., Younkin L.H., Suzuki N., Younkin S.G. Amyloid β protein (Aβ) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms of Aβ40 and Aβ42(43). J. Biol. Chem. 270:1995;7013-7016.
2. Hayes A., Batshaw M.L. Down syndrome. Pediatr. Clin. North Am. 40:1994;523-529.
3. Iwatsubo T., Mann D.M.A., Odaka A., Suzuki N., Ihara Y. Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in Down syndrome. Ann. Neurol. 37:1995;294-299.
4. Iwatsubo T., Odaka A., Suzuki N., Mizusawa H., Nukina N., Ihara Y. Visualization of Aβ42/43 and Aβ40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ42/43. Neuron. 13:1994;45-53.
5. Mann, D.M.A., Association between Alzheimer disease and Down syndrome. In J.M. Berg, H. Karlinsky and A.J. Holland (Eds.), Alzheimer Disease, Down Syndrome and Their Relationship, Oxford University Press, Oxford, 1993, pp. 71-92.
6. Mehta P.D., Dalton A.J., Mehta S.P., Kim K.S., Wisniewski H.M. Plasma amyloid β (Aβ) 1-42 levels are increased in Down syndrome (DS) but not in Alzheimer disease (AD). Ann. Neurol. (Abstr.). 42:1997;400.
7. Rumble B., Retallack R., Hilbich C., Simms G., Multhaup G., Martins R., Hockey A., Montgomery P., Beyreuther K., Masters C.L. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N. Engl. J. Med. 320:1989;1446-1452.
8. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T.D., Hardy J., Hutton M., Kukull W., Larson E., Levy-Lahad E., Viitanen M., Peskind E., Poorkaj P., Schellenberg G., Tanzi R., Wasco W., Lannfelt L., Selkoe D., Younkin S. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med. 2(8):1996;864-870.
9. Selkoe D. Normal and abnormal biology of the β-amyloid precursor protein. Annu. Rev. Neurosci. 17:1994;489-517.
10. Tamaoka A., Fukushima T., Sawamura N., Ishikawa K., Oguni E., Komatsuzaki Y., Shoji S. Amyloid β protein in plasma from patients with sporadic Alzheimer's disease. J. Neurol. Sci. 151:1996;65-68.
11. Tanzi R.E., Gusella J.F., Watkins P.C. Amyloid-beta protein gene: cDNA, mRNA distribution and genetic linkage near the Alzheimer locus. Science. 235:1987;880-884.
12. Tanzi R.E. Neuropathology in the Down's syndrome brain. Nature Med. 2:1996;31-32.
13. Teller J.K., Russo C., DeBusk L.M., Angelini G., Zaccheo D., Dagna-Bricarelli F., Scartezzini P., Bertolini S., Mann D.M.A., Tabaton M., Gambetti P. Presence of soluble amyloid β-peptide precedes amyloid plaque formation in Down's syndrome. Nature Med. 2(1):1996;93-95.
14. Tokuda T., Fukushima T., Ikeda S., Sekijima Y., Shoji S., Yanagisawa N., Tamaoka A. Plasma levels of amyloid β proteins Aβ1-40 and Aβ1-42(43) are elevated in Down's syndrome. Ann. Neurol. 41:1997;271-273.
15. Wisniewski H.M., Wegiel J. The neuropathology of Alzheimer's disease. Neuroimag. Clin. North. Am. 5:1995;45-57.
16. Wisniewski H.M., Wegiel J., Popovitch E.R. Age-associated development of diffuse and thioflavin-S-positive plaques in Down syndrome. Dev. Brain Dysfunct. 7:1994;330-339.
17. Wisniewski K.E., Dalton A.J., Crapper McLachlan D.R., Wen G.Y., Wisniewski H.M. Alzheimer's disease in Down's syndrome. Neurology. 35:1985;957-961.
18. Wisniewski, H.M., On the importance of the cellular origin of Aβ in Alzheimer's disease. In K. Iqbal, B. Winblad, T. Nishimura, M. Takeda and H.M. Wisniewski (Eds.), Alzheimer's Disease: Biology, Diagnosis and Therapeutics, Wiley, New York, 1997, pp. 321-326.